Clinical trial
Evaluation of Risk Factors for Therapeutic Outcome in Patients with Tachycardiomyopathy
NCT03418467 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Risk Factors for Therapeutic Outcome in Patients with Tachycardiomyopathy
- Lead sponsor
- University Hospital Tuebingen
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- October 11, 2018
- Completion date
- May 31, 2030
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.